MD Anderson is a major referral center for patients with mantle cell lymphoma (MCL) and treats more patients with this disease than any other cancer center in the United States. In 2014, the Kinder Foundation committed $1 million to MD Anderson to advance studies that develop more effective, durable treatments. The gift supports the research led by Michael Wang, M.D. professor in Lymphoma/Myeloma and director of MD Anderson’s MCL Program of Excellence.

It is the hope of the Foundation that the work of MD Anderson and Dr. Wang leads to more effective treatment, patient care and outcomes for MCL patients.

mdanderson.org